These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 14702693)

  • 1. [The generic Research and Development possibilities after Hungary accessed th European Patent Convention].
    Kelen A; Angyal N; Máthé Z; Bódis A; Hódi K
    Acta Pharm Hung; 2003; 73(2):123-9. PubMed ID: 14702693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
    Schrell A; Bauser H; Brunner H
    Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical questions to ponder in the European stem cell patent debate.
    Curley D; Sharples A
    J Biolaw Bus; 2006; 9(3):12-6. PubMed ID: 17152135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patenting biotechnologies: the European Union Directive 98/44/EC of the European parliament and of the council of 6th July 1998 on the legal protection of biotechnological inventions.
    Morelli Gradi G
    Forum (Genova); 1999; 9(3 Suppl 3):25-36. PubMed ID: 10607844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent protection for stem cell procedures under the law of the European Union.
    Spranger TM
    Med Etika Bioet; 2003; 10(1-2):4-8. PubMed ID: 16294439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The patentability of living organisms between science, law and ethics.
    Frati L; Foà R; Frati P
    Forum (Genova); 1999; 9(3 Suppl 3):8-14. PubMed ID: 10607843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between the academic community and the pharmaceutical industry: the legislative background and its effect on spending on medical research and development.
    Matthews JH
    Clin Invest Med; 1996 Dec; 19(6):470-8. PubMed ID: 8959357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent prosecution at the European Patent Office: what is new for life sciences applicants?
    Lidén C; Setréus E
    Expert Opin Ther Pat; 2011 Jun; 21(6):813-7. PubMed ID: 21457106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards harmonization: the European biotechnology patent directive.
    Curley D
    J Biolaw Bus; 2002; 5(3):64-8. PubMed ID: 12816122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patent protection in modern medical technology].
    Bosch M
    Biomed Tech (Berl); 2002; 47 Suppl 1 Pt 2():686-7. PubMed ID: 12465274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research exemption/experimental use in the European Union: patents do not block the progress of science.
    Jaenichen HR; Pitz J
    Cold Spring Harb Perspect Med; 2014 Nov; 5(2):a020941. PubMed ID: 25377145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
    Aymé S; Matthijs G; Soini S;
    Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protecting new ideas and inventions in nanomedicine with patents.
    Bawa R; Bawa SR; Maebius SB; Flynn T; Wei C
    Nanomedicine; 2005 Jun; 1(2):150-8. PubMed ID: 17292072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patents on diagnostic methods in Europe under the European Patent Convention (EPC).
    Barba M
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():2979-81. PubMed ID: 21095714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The university-promoted patent at the crossroads of the research results and immediate industrial use.
    Doddoli R
    Biomol Eng; 2007 Feb; 24(1):43-6. PubMed ID: 16890015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Opposition to Myriad Genetics patents and their total or partial revocation in Europe: early conclusions].
    Cassier M; Stoppa-Lyonnet D
    Med Sci (Paris); 2005; 21(6-7):658-62. PubMed ID: 15985212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Sufficiency" for living organism inventions under the Patents Act 1990 (Cth).
    Lawson C
    J Law Med; 2004 Feb; 11(3):373-81. PubMed ID: 15018213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ownership of knowledge--the role of patents in pharmaceutical R&D.
    Correa CM
    Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient rights in EU Member States after the ratification of the Convention on Human Rights and Biomedicine.
    Nys H; Stultiëns L; Borry P; Goffin T; Dierickx K
    Health Policy; 2007 Oct; 83(2-3):223-35. PubMed ID: 17379350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.